An observational study in Surgical Wound, sponsored by University of Chile. Suspended at 2 sites in Chile. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-30.
Sponsored by University of Chile · Observational
After surgical tissue damage, cellular blood components are involved in tissue repair processes, yet their preoperative characteristics are not considered in routine clinical practice.
Surgical injuries initiate the recruitment of cellular blood components for tissue repair. Baseline inflammation levels and cellular response to tissue damage are absent from perioperative management algorithms despite their importance in regeneration. This project seeks to examine patients preoperative parameters before surgery and evaluate if there is a correlation with clinical outcomes.
521 studies on the registry are indexed under Surgical Wound; 69 are open to participants now.
This study's planned enrollment of 40 is below the median of 113 across 83 observational studies indexed under Surgical Wound.
Browse Surgical Wound studies →University of Chile is the lead sponsor of 194 studies on the registry; 38 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with acute intrabdominal pathology who requires surgery in the next 24 hours.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with high neutrophil count in their preoperative complete blood count
Patients with low neutrophil count in their preoperative complete blood count
Death
The number of deceased patients.
Time frame: 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is suspended, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.